pxradia.com
Contáctenos
Acerca de la compañía
PxRadia was formed in 2010 by Dr. Charles Morgan, a founder of multiple companies and a pioneer in monoclonal antibody development, with an exclusive license from Memorial Sloan-Kettering Cancer Center to commercialize the breakthrough research of Dr. Richard N. Kolesnick on the role of ceramide, a lipid, in cell signaling and cell death.
US
Desconocido
Empresa no verificada
Transparencia empresarial
- No verificó la información de la empresa
- Pide reseñas a sus clientes
- No respondió a las críticas negativas.